Literature DB >> 19026809

The bidirectional Glenn operation: a risk factor analysis for morbidity and mortality.

Brian E Kogon1, Courtney Plattner, Traci Leong, Janet Simsic, Paul M Kirshbom, Kirk R Kanter.   

Abstract

OBJECTIVE: Patients with single ventricle heart defects often undergo a palliative bidirectional Glenn operation. For this operation, we analyzed potential risk factors for morbidity and mortality. We also evaluated the effects of a persistent left superior vena cava by comparing the outcomes of unilateral and bilateral operations.
METHODS: We reviewed the clinical records of 270 consecutive patients who underwent a bidirectional Glenn operation between 2001 and 2007. A total of 226 patients underwent unilateral operations and 44 patients underwent bilateral operations. Patient characteristics included weight and age, single ventricle morphology, vena caval anatomy, and previous surgery. Operative details included cardiopulmonary bypass technique and duration, pulmonary artery management, hemi-Fontan construction, concomitant procedures, and hemodynamics. Outcome data included duration of chest tube drainage, lengths of intensive care unit and hospital stay, morbidity, and mortality (<30 days).
RESULTS: The median length of chest tube drainage was 2.4 days (range 1-20 days). Risk factors for prolonged drainage were elevated central venous pressure (P = .015) and transpulmonary gradient (P = .011). The median lengths of stay in the intensive care unit and hospital were 50 hours (range 20-1628 hours) and 5 days (range 2-83 days), respectively. Risk factors for both included prolonged cardiopulmonary bypass time, elevated central venous pressure and transpulmonary gradient, and right ventricular morphology. Overall, 72 of 270 patients (27%) had 116 postoperative complications. Risk factors included prolonged cardiopulmonary bypass time (P = .002) and elevated central venous pressure (P = .029). Mortality was 2 of 270 patients (0.7%). No risk factors for death were identified. Weight (median 6.8 kg vs 6.2 kg, P = .038) and age (median 186 days vs 159 days, P = .001) at the time of surgery were significantly greater in the bilateral bidirectional Glenn group compared with the unilateral group. However, there was no difference in any of the outcome variables.
CONCLUSION: Outcomes were adversely affected primarily by prolonged cardiopulmonary bypass time, elevated central venous pressure and transpulmonary gradient, and right ventricular morphology. Specifically, outcomes were unaffected by the presence of a left superior vena cava, cannulation strategy, or antegrade pulmonary blood flow. There were few differences between the unilateral and bilateral groups, none of which were postoperative outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 19026809     DOI: 10.1016/j.jtcvs.2008.05.017

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  22 in total

1.  First-in-Human Closed-Chest Transcatheter Superior Cavopulmonary Anastomosis.

Authors:  Kanishka Ratnayaka; John W Moore; Rodrigo Rios; Robert J Lederman; Sanjeet R Hegde; Howaida G El-Said
Journal:  J Am Coll Cardiol       Date:  2017-08-08       Impact factor: 24.094

2.  Development of a thermodynamic control system for the Fontan circulation pulsation device using shape memory alloy fibers.

Authors:  Akihiro Yamada; Yasuyuki Shiraishi; Hidekazu Miura; Hashem Mohamed Omran Hashem; Yusuke Tsuboko; Masaaki Yamagishi; Tomoyuki Yambe
Journal:  J Artif Organs       Date:  2015-04-18       Impact factor: 1.731

3.  Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database.

Authors:  Carissa M Baker-Smith; Sara W Goldberg; Geoffrey L Rosenthal
Journal:  Pediatr Cardiol       Date:  2015-06-03       Impact factor: 1.655

4.  Variation in models of care delivery for children undergoing congenital heart surgery in the United States.

Authors:  Danielle S Burstein; Anthony F Rossi; Jeffrey P Jacobs; Paul A Checchia; Gil Wernovsky; Jennifer S Li; Sara K Pasquali
Journal:  World J Pediatr Congenit Heart Surg       Date:  2010-04

5.  Interstage Weight Gain Is Associated With Survival After First-Stage Single-Ventricle Palliation.

Authors:  Charles F Evans; John D Sorkin; Danielle S Abraham; Brody Wehman; Sunjay Kaushal; Geoffrey L Rosenthal
Journal:  Ann Thorac Surg       Date:  2017-03-24       Impact factor: 4.330

6.  Elevated Pulmonary Artery Pressure, Not Pulmonary Vascular Resistance, is an Independent Predictor of Short-Term Morbidity Following Bidirectional Cavopulmonary Connection.

Authors:  Susanna Tran; Patrick M Sullivan; John Cleveland; S Ram Kumar; Cheryl Takao
Journal:  Pediatr Cardiol       Date:  2018-06-14       Impact factor: 1.655

7.  The Optimal Timing of Stage-2-Palliation After the Norwood Operation.

Authors:  James M Meza; Edward Hickey; Brian McCrindle; Eugene Blackstone; Brett Anderson; David Overman; James K Kirklin; Tara Karamlou; Christopher Caldarone; Richard Kim; William DeCampli; Marshall Jacobs; Kristine Guleserian; Jeffrey P Jacobs; Robert Jaquiss
Journal:  Ann Thorac Surg       Date:  2017-08-25       Impact factor: 4.330

8.  Outcomes of infants undergoing superior cavopulmonary connection in the presence of ventricular dysfunction.

Authors:  Matthew J O'Connor; Matthew D Elias; Meryl S Cohen; Michael D Quartermain
Journal:  Pediatr Cardiol       Date:  2011-11-19       Impact factor: 1.655

9.  Superior cavopulmonary anastomosis timing and outcomes in infants with single ventricle.

Authors:  James F Cnota; Kerstin R Allen; Steven Colan; Wesley Covitz; Eric M Graham; David A Hehir; Jami C Levine; Renee Margossian; Brian W McCrindle; L LuAnn Minich; Shobha Natarajan; Marc E Richmond; Daphne T Hsu
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-28       Impact factor: 5.209

10.  Phosphodiesterase-5 Is Elevated in Failing Single Ventricle Myocardium and Affects Cardiomyocyte Remodeling In Vitro.

Authors:  Anastacia M Garcia; Stephanie J Nakano; Anis Karimpour-Fard; Karin Nunley; Penny Blain-Nelson; Natalie M Stafford; Brian L Stauffer; Carmen C Sucharov; Shelley D Miyamoto
Journal:  Circ Heart Fail       Date:  2018-09       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.